Feras Darwish Walid Darwish El-Hajji

Dr. Feras Darwish Walid Darwish El-Hajji

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2011 in Journal of Hospital Infection
Verified
Journal Article
Closed access
YAY.M. Alahmadi
Y.M. Alahmadi
MAMamoon Aldeyab
Mamoon Aldeyab
JMJ.C. McElnay
J.C. McElnay
Michael ScottMichael Scott
Michael Scott
FEFeras Darwish Walid Darwish El-Hajji
Feras Darwish Walid Darwish El-Hajji
MKM.P. Kearney
M.P. Kearney

16 August 2012 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
MAMamoon Aldeyab
Mamoon Aldeyab
MKMary P. Kearney
Mary P. Kearney
Michael ScottMichael Scott
Michael Scott
MAMotasem A. Aldiab
Motasem A. Aldiab
YAYaser M. Alahmadi
Yaser M. Alahmadi
JMJames C. McElnay
James C. McElnay
To evaluate the impact of a high-risk antibiotic stewardship programme on reducing antibiotic use and on hospital Clostridium difficile infection (CDI) incidence rates. A secondary objective was to present the possible utility of time-series analysis as an antibiotic risk classification tool. This was an interventional, retrospective, ecological investigation in a medium-sized hospital over 6.5 years (January 2004 to June 2010). The intervention was the restriction of high-risk antibiotics (second-generation cephalosporins, third-generation cephalosporins, fluoroquinolones and clindamycin). Amoxicillin/clavulanic acid and macrolides were classified as medium-risk antibiotics based on time-series analysis findings and their use was monitored. The intervention was evaluated by segmented regression analysis of interrupted time series. The intervention was associated with a significant change in level of use of high-risk antibiotics (coefficient −17.3, P < 0.0001) and with a borderline significant trend change in their use being reduced by 0.156 defined daily doses/100 bed-days per month (P = 0.0597). The reduction in the use of high-risk antibiotics was associated with a significant change in the incidence trend of CDI (P = 0.0081), i.e. the CDI incidence rate decreased by 0.0047/100 bed-days per month. Analysis showed that variations in the incidence of CDI were affected by the age-adjusted comorbidity index with a lag of 1 month (coefficient 0.137051, P = 0.0182). Significant decreases in slope (coefficient −0.414, P = 0.0309) post-intervention were also observed for the monitored medium-risk antibiotics. The restriction of the high-risk antibiotics contributed to both a reduction in their use and a reduction in the incidence of CDI in the study site hospital. Time-series analysis can be utilized as a risk classification tool with utility in antibiotic stewardship design and quality improvement programmes.

9 December 2011 in British Journal of Clinical Pharmacology
Verified
Journal Article
Open access
PDF file
MAMamoon Aldeyab
Mamoon Aldeyab
SHStephan Harbarth
Stephan Harbarth
NVNathalie Vernaz
Nathalie Vernaz
MKMary P. Kearney
Mary P. Kearney
Michael ScottMichael Scott
Michael Scott
JMJames C. McElnay
James C. McElnay
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT• The emergence and spread of bacteria producing extended‐spectrum beta‐lactamases (ESBLs) has important therapeutic and epidemiologic implications.• A key target for the establishment of hospital antibiotic stewardship is reducing the occurrence of additional antibiotic resistance.• Further research is needed to accumulate supporting evidence that reducing antibiotic use will result in a parallel reduction in antibiotic resistance.WHAT THIS STUDY ADDS• Fluoroquinolone restriction reversed ciprofloxacin resistance in primary and secondary healthcare settings.• Fluoroquinolone restriction reduced ESBL‐producing bacteria incidence rates in both the primary and secondary healthcare settings.• This study highlights the value of time‐series analysis in designing efficient antibiotic stewardship.AIMS: The objective of the present study was to study the relationship between hospital antibiotic use, community antibiotic use and the incidence of extended‐spectrum beta‐lactamase (ESBL)‐producing bacteria in hospitals, while assessing the impact of a fluoroquinolone restriction policy on ESBL‐producing bacteria incidence rates.METHODS: The study was retrospective and ecological in design. A multivariate autoregressive integrated moving average (ARIMA) model was built to relate antibiotic use to ESB‐producing bacteria incidence rates and resistance patterns over a 5 year period (January 2005–December 2009).RESULTS: Analysis showed that the hospital incidence of ESBLs had a positive relationship with the use of fluoroquinolones in the hospital (coefficient = 0.174, P= 0.02), amoxicillin‐clavulanic acid in the community (coefficient = 1.03, P= 0.03) and mean co‐morbidity scores for hospitalized patients (coefficient = 2.15, P= 0.03) with various time lags. The fluoroquinolone restriction policy was implemented successfully with the mean use of fluoroquinolones (mainly ciprofloxacin) being reduced from 133 to 17 defined daily doses (DDDs)/1000 bed days (P < 0.001) and from 0.65 to 0.54 DDDs/1000 inhabitants/day (P= 0.0007), in both the hospital and its surrounding community, respectively. This was associated with an improved ciprofloxacin susceptibility in both settings [ciprofloxacin susceptibility being improved from 16% to 28% in the community (P < 0.001)] and with a statistically significant reduction in ESBL‐producing bacteria incidence rates.DISCUSSION: This study supports the value of restricting the use of certain antimicrobial classes to control ESBL, and demonstrates the feasibility of reversing resistance patterns post successful antibiotic restriction. The study also highlights the potential value of the time‐series analysis in designing efficient antibiotic stewardship.

1 March 2011 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
MAMamoon Aldeyab
Mamoon Aldeyab
MDMichael J. Devine
Michael J. Devine
PFPeter Flanagan
Peter Flanagan
MMMichael Mannion
Michael Mannion
ACAvril Craig
Avril Craig
MKMary P. Kearney
Mary P. Kearney
Objective.: To report a large outbreak ofClostridium difficileinfection (CDI; ribotype 027) between June 2007 and August 2008, describe infection control measures, and evaluate the impact of restricting the use of fluoroquinolones in controlling the outbreak.Design.: Outbreak investigation in 3 acute care hospitals of the Northern Health and Social Care Trust in Northern Ireland.Interventions.: Implementation of a series of CDI control measures that targeted high-risk antibiotic agents (ie, restriction of fluoroquinolones), infection control practices, and environmental hygiene.Results.: A total of 318 cases of CDI were identified during the outbreak, which was the result of the interaction betweenC. difficileribotype 027 being introduced into the affected hospitals for the first time and other predisposing risk factors (ranging from host factors to suboptimal compliance with antibiotic guidelines and infection control policies). The 30-day all-cause mortality rate was 24.5%; however, CDI was the attributable cause of death for only 2.5% of the infected patients. Time series analysis showed that restricting the use of fluoroquinolones was associated with a significant reduction in the incidence of CDI (coefficient, —0.054; lag time, 4 months;P= .003).Conclusion.: These findings provide additional evidence to support the value of antimicrobial stewardship as an essential element of multifaceted interventions to control CDI outbreaks. The present CDI outbreak was ended following the implementation of an action plan improving communication, antibiotic stewardship, infection control practices, environmental hygiene, and surveillance.

12 November 2018 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
FEFeras Darwish Walid Darwish El-Hajji
Feras Darwish Walid Darwish El-Hajji
GAGhaith Al-Taani
Ghaith Al-Taani
LALana Anani
Lana Anani
SASahar Al-Masri
Sahar Al-Masri
HAHaneen Abdalaziz
Haneen Abdalaziz
MAMamoon Aldeyab
Mamoon Aldeyab
To assess antimicrobial prescribing in a Northern Ireland hospital (Antrim Area Hospital (AAH)) and compare them with those of a hospital in Jordan (Specialty Hospital). Using the Global-PPS approach, the present study surveyed patients admitted to the hospital in 2015, the prescribed antibiotics, and a set of quality control indicators related to antibiotics. Ultimately, 444 and 112 inpatients in the AAH and the Specialty Hospital, respectively, were surveyed. For the medical group, 165 inpatients were prescribed 239 antibiotics in the AAH, while 44 patients in the Specialty Hospital were prescribed 65 antibiotics. In relation to the surgical group, 34 inpatients treated for infection were prescribed 66 antibiotics in the AAH, while 41 patients in the Specialty Hospital treated for infection were prescribed 56 antibiotics. For the medical patients, the most frequently prescribed antibiotics in the AAH were a combination of penicillins (18.8%) and penicillins with extended spectrum (18.8%). For the surgical patients, the most frequently prescribed antibiotics in the AAH were imidazole derivatives (24.2%). For the medical and surgical patients in the Specialty Hospital, the most frequently prescribed antibiotics were third-generation cephalosporins (26.2 and 37.5%, respectively). In medical patients, compliance to guidelines was 92.2% in the Specialty Hospital compared to 72.0% in the AAH (p < 0.001). In surgical patients, compliance to guidelines was 92.7% in the Specialty Hospital compared to 81.8% in the AAH (p = 0.012). The present study highlighted differences in the utilisation of antimicrobials between two hospitals in two distinct regions and benchmarked antibiotic prescriptions across two hospitals.

23 May 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
SASalam Abu-Ajaleh
Salam Abu-Ajaleh
FEFeras Darwish Walid Darwish El-Hajji
Feras Darwish Walid Darwish El-Hajji
SAShatha Al-Bsoul
Shatha Al-Bsoul
RFRana Abu Farha
Rana Abu Farha
FAFawzi Al-Hammouri
Fawzi Al-Hammouri
MAMamoon Aldeyab
Mamoon Aldeyab
The study aims to determine the effect of enhancing knowledge and awareness of the WHO Access, Watch, and Reserve (AWaRe) antibiotics classification on hospital clinical staff’s knowledge, attitudes and antibiotic prescribing practices. A pre-post-intervention study design was employed. The intervention was an educational activity that involved teaching physicians and pharmacists about the AWaRe classification and the risk of antibiotic resistance. A questionnaire was administered to clinical staff pre-and post-intervention. In the pre-interventional stage, 78.5% of participants stated they had not heard about the AWaRe classification of antibiotics. After receiving the intervention: the knowledge regarding the meaning and purpose of AWaRe classification of antibiotics increased from 39.1% to 75.4%; the percentage of participants who agreed with following the AWaRe classification of antibiotics in their practice increased from 21.7% to 58.5%; and the percentage of participants who agreed that AWaRe classification of antibiotics can suggest safe choices of antibiotics increased from 56.5% to 90.8%. Hospital antibiotic use of the Access group increased by 6.6% from pre- to post-intervention. The use of the Watch group and Reserve group decreased post-intervention by 1.7%, and 43.1%, respectively. This study showed important gaps in knowledge and attitudes towards AWaRe, highlighting the need for increasing the awareness of the AWaRe tool amongst healthcare practitioners to ensure rational use of antibiotics.